ClinOne: Using Mobile Technology to Improve Clinical Trial Self-Dosing Compliance

DENVER, Jan. 9, 2019 /PRNewswire/ -- The costs and timelines to conduct clinical trials continue to increase, as does study complexity. While much of the focus in clinical trials has been on improving data quality and overall study efficiency in order to address cost/timeline/complexity issues, less attention has been paid to the impact of patient non-compliance to drug treatment.

It's estimated that after just three months on trial, patient dose compliance drops to 75 percent and at 10 months, that compliance rate drops to 60 percent. Consider the implications of this non-compliance:

• In order to maintain the power of the study, more patients must be recruited
• This often requires opening additional sites
• Drug accountability at time of study close-out can prove to be more burdensome
• All of which mean extending the study timeline
• All of the above mean the study will cost significantly more to conduct

ClinOne has introduced Doe Manager, a cost-effective mobile solution to help address this problem. Utilizing simple text messaging, automated reminders are sent to patients (as well as caregivers, as needed) to encourage them to take their medication. Similarly, research sites receive alerts to signify the need for follow-up. Sponsors and CROs benefit from reports that are designed to highlight sites where non-compliance may be a concern, thus allowing for more focused monitoring visits.

"It's estimated that 91 percent of mobile users keep their phone within arm's reach 24/7, while 90 percent of all text messages are read within three minutes of receipt, so this is a highly effective means of engaging the patient and driving better dose compliance," says Rob Bohacs, ClinOne's founder and CEO.

About ClinOne
ClinOne offers a complete suite of mobile and web applications to enhance patient, caregiver and site engagement. Currently, our solutions help support close to 3,000 clinical studies, across 1,900 research sites in over 50 countries. If interested in learning more or scheduling a demo, contact us. Visit www.clinone.com for more information.

View original content:http://www.prnewswire.com/news-releases/clinone-using-mobile-technology-to-improve-clinical-trial-self-dosing-compliance-300775400.html

SOURCE ClinOne Inc.

[ Back To TMCnet.com's Homepage ]